Eledon Pharmaceuticals (ELDN) Change in Cash (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Change in Cash of -$16.7 million for Q1 2026, down 187.03% on a QoQ basis from $19.1 million in Q4 2025, and down 38.19% year-over-year from -$26.9 million in Q1 2025.
Eledon Pharmaceuticals (ELDN) Change in Cash (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Change in Cash history runs 14 years deep, the most recent figure standing at -$16.7 million for Q1 2026.
- Quarterly Change in Cash fell 38.19% year-over-year to -$16.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 182.51% YoY) and the FY2025 annual result came in at $2.3 million, down 85.83% from the prior year.
- Change in Cash was -$16.7 million for Q1 2026 at Eledon Pharmaceuticals, down from $19.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $20.4 million in Q2 2024 and bottomed at -$37.3 million in Q3 2023.
- A 5-year average of -$4.6 million and a median of -$5.5 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 1360.11% — and 2025, when it sank 1255.61%.
- Eledon Pharmaceuticals' Change in Cash stood at -$9.5 million in 2022, then soared by 109.97% to $945000.0 in 2023, then soared by 1360.11% to $13.8 million in 2024, then jumped by 38.71% to $19.1 million in 2025, then tumbled by 187.03% to -$16.7 million in 2026.
- Business Quant data shows ELDN's Change in Cash at -$16.7 million in Q1 2026, $19.1 million in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Eledon Pharmaceuticals | 406.41 Mn | 406.41 Mn | - | -16.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.66 Mn |
| Dec 31, 2025 | 19.14 Mn |
| Sep 30, 2025 | -2.07 Mn |
| Jun 30, 2025 | -2.76 Mn |
| Mar 31, 2025 | -12.05 Mn |
| Dec 31, 2024 | 13.80 Mn |
| Sep 30, 2024 | -19.29 Mn |
| Jun 30, 2024 | 20.38 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 945,000.00 |
| Sep 30, 2023 | -37.28 Mn |
| Jun 30, 2023 | -5.54 Mn |
| Mar 31, 2023 | -9.92 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Sep 30, 2022 | -4.57 Mn |
| Jun 30, 2022 | -6.22 Mn |
| Mar 31, 2022 | -8.16 Mn |
| Dec 31, 2021 | -9.21 Mn |
| Sep 30, 2021 | -7.09 Mn |
| Jun 30, 2021 | -7.45 Mn |